Kendamil Classic

FDA recall and outbreak record for the brand's formula over five years: Strong. FDA's enforcement report search for Kendamil returns two Class II entries from 8 August 2021, both terminated, from the importer Able Groupe for Kendamil Organic Stage 1 and Stage 2 formulas, because the 'required pre-market notifications' had not been submitted. They fall just outside the five-year window, so no deduction is made. FDA's list of infant formulas marketed in the US, current as of 1 September 2026, includes Kendamil Infant Formula. source↗ 2026-09